The FDA has approved Ozempic to reduce the risk of kidney disease worsening, kidney failure and cardiovascular-related death in adults with Type 2 diabetes and chronic kidney disease. This new ...

A Phase 3 clinical trial found that injections of the semaglutide medication once weekly reduced the risk of kidney disease worsening by 24% in people who also had diabetes. It also reduced the ...

The medication lowered the risk of kidney failure and slashed the mortality risk from heart disease by about 5% in adults with diabetes and CKD. Those taking the drug saw the risk for heart attack ...

Ozempic, the blockbuster GLP-1 drug that was originally approved to treat type 2 diabetes ... of the semaglutide medication once weekly reduced the risk of kidney disease worsening by 24% in ...

The Food and Drug Administration approved Novo Nordisk's Ozempic for patients with both chronic kidney disease and diabetes ... So if you have a medicine that can target each of these co ...

THESE DRUGS COULD POSSIBLY PREVENT HEART ATTACK AND STROKE. THE RESULTS ARE PROMISING FOR HEART PATIENTS.. THESE MEDICATIONS ARE MOSTLY KNOWN FOR TREATING DIABETES AND OBESITY.. BUT THE F-D-A HAS ...